{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T14:04:23Z","timestamp":1772633063490,"version":"3.50.1"},"reference-count":139,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":1711,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1038\/ki.2010.545","type":"journal-article","created":{"date-parts":[[2011,1,19]],"date-time":"2011-01-19T10:01:34Z","timestamp":1295431294000},"page":"825-842","source":"Crossref","is-referenced-by-count":60,"title":["Renal transplantation in HIV-infected patients: 2010 update"],"prefix":"10.1016","volume":"79","author":[{"given":"Joan C.","family":"Trullas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Cofan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montse","family":"Tuset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda J.","family":"Ricart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Manzardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"L\u00f3pez-Dieguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Oppenheimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asuncion","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep M.","family":"Campistol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose M.","family":"Miro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2010.545_bb0010","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/00002030-200208160-00012","article-title":"Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study","volume":"16","author":"Mocroft","year":"2002","journal-title":"AIDS"},{"key":"10.1038\/ki.2010.545_bb0015","first-page":"24","article-title":"Liver transplantation in HIV\/hepatitis co-infection","volume":"12","author":"Miro","year":"2007","journal-title":"J HIV Ther"},{"key":"10.1038\/ki.2010.545_bb0020","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1093\/ndt\/gfq125","article-title":"Kidney transplants in HIV-positive recipients under HAART. A comprehensive review and meta-analysis of 12 series","volume":"25","author":"Landin","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2010.545_bb0025","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1523-1755.2005.67096.x","article-title":"HAART-related nephropathies in HIV-infected patients","volume":"67","author":"Daugas","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.545_bb0030","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1086\/503566","article-title":"HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy","volume":"42","author":"R\u00f6ling","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1038\/ki.2010.545_bb0035","doi-asserted-by":"crossref","first-page":"214","DOI":"10.7326\/0003-4819-139-3-200308050-00011","article-title":"Pathogenesis and treatment of HIV-associated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations","volume":"139","author":"Kimmel","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.2010.545_bb0040","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1093\/ndt\/gfl337","article-title":"Antiretroviral therapy in the treatment of HIV-associated nephropathy","volume":"21","author":"Atta","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2010.545_bb0045","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1086\/523728","article-title":"Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland","volume":"45","author":"Atta","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1038\/ki.2010.545_bb0050","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/QAI.0b013e3181efbe59","article-title":"Dialysis and renal transplantation in HIV-infected patients: a European survey","volume":"55","author":"Trullas","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1038\/ki.2010.545_bb0055","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1525-139X.2005.18108.x","article-title":"National surveillance of dialysis-associated diseases in the United States, 2002","volume":"18","author":"Finelli","year":"2005","journal-title":"Semin Dial"},{"key":"10.1038\/ki.2010.545_bb0060","series-title":"International Yearbook of Nephrology 1991","first-page":"199","article-title":"Acquired immunodeficiency syndrome (AIDS), human immunodeficiency virus (HIV), and dialysis","author":"Rao","year":"1990"},{"issue":"Suppl 4","key":"10.1038\/ki.2010.545_bb0065","first-page":"5","article-title":"Combined report on regular dialysis and transplantation in Europe, XXI, 1990","volume":"6","author":"Geerlings","year":"1991","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2010.545_bb0070","first-page":"249","article-title":"HIV infection in dialysis centers in Italy: a nationwide multicenter study","volume":"11","author":"Barbiano di Belgiojoso","year":"1998","journal-title":"J Nephrol"},{"key":"10.1038\/ki.2010.545_bb0075","first-page":"159","article-title":"Prevalence of HIV infection in dialysis patients: results of a national multicenter study","volume":"20","author":"Poignet","year":"1999","journal-title":"Nephrologie"},{"key":"10.1038\/ki.2010.545_bb0080","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1523-1755.2005.00229.x","article-title":"The clinical characteristics of HIV-infected patients receiving dialysis in France between 1997 and 2002","volume":"67","author":"Vigneau","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.545_bb0085","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1157\/13076172","article-title":"Prevalence of HIV-1-infection in dialysis units in Spain and potential candidates for renal transplantation: results of a Spanish survey","volume":"23","author":"Barril","year":"2005","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1038\/ki.2010.545_bb0090","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1089\/aid.2008.0158","article-title":"Prevalence and clinical characteristics of HIV-1-infected patients receiving dialysis in Spain: results of a Spanish survey in 2006","volume":"24","author":"Trull\u00e0s","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1038\/ki.2010.545_bb0095","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/00002030-199406000-00023","article-title":"HIV infection in renal dialysis patients in Egypt","volume":"8","author":"Hassan","year":"1994","journal-title":"AIDS"},{"key":"10.1038\/ki.2010.545_bb0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000185129","article-title":"Prevalence of ATLV and HIV among hemodialysis patients in Japan","volume":"50","author":"Morikawa","year":"1988","journal-title":"Nephron"},{"key":"10.1038\/ki.2010.545_bb0105","series-title":"Anti-HIV antibodies in population of 132 patients in hemodialysis (Abstract)","author":"Falcao","year":"1987"},{"key":"10.1038\/ki.2010.545_bb0110","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/ki.1988.172","article-title":"Outcome of patients with human immunodeficiency virus on maintenance hemodialysis","volume":"34","author":"Ortiz","year":"1988","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.545_bb0115","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1097\/01.ASN.0000019773.43765.BF","article-title":"Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States","volume":"13","author":"Ahuja","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.545_bb0120","series-title":"Outcome and Prognostic Factors in HIV-1-Infected Dialysis Patients in Spain in the HAART Era: A Case-Control GESIDA\/SEN Study","author":"Trull\u00e0s","year":"2010"},{"key":"10.1038\/ki.2010.545_bb0125","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/01.ASN.0000062963.56513.28","article-title":"Determinants of survival among HIV-infected chronic dialysis patients","volume":"14","author":"Rodriguez","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.545_bb0130","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2215\/CJN.02211205","article-title":"Outcome and prognosis factors in HIV-infected hemodialysis patients","volume":"1","author":"Tourret","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.545_bb0135","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1086\/523729","article-title":"Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease","volume":"45","author":"Choi","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1038\/ki.2010.545_or0010","unstructured":"Solid Organ Transplantation in HIV: Multi-Site Study [Last accessed 19 August 2010]. Available at:www.hivtransplant.com"},{"issue":"Suppl 10","key":"10.1038\/ki.2010.545_bb0145","first-page":"83","article-title":"Solid organ transplantation in the HIV-infected patient","volume":"4","author":"Anonymous","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2010.545_bb0150","first-page":"353","article-title":"GESIDA\/GESITRA-SEIMC, PNS and ONT consensus document on solid organ transplant (SOT) in HIV-infected patients in Spain (March, 2005)","volume":"23","author":"Miro","year":"2005","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1038\/ki.2010.545_bb0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1468-1293.2006.00367.x","article-title":"Guidelines for kidney transplantation in patients with HIV disease","volume":"7","author":"Bhagani","year":"2006","journal-title":"HIV Med"},{"issue":"Suppl 2","key":"10.1038\/ki.2010.545_bb0160","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/00007890-200607152-01125","article-title":"Liver transplantation in HIV-infected individuals: results of the Italian national program","volume":"82","author":"Grossi","year":"2006","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.545_bb0165","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1056\/NEJM200011233432106","article-title":"Racial disparities in access to renal transplantation\u2013clinically appropriate or due to underuse or overuse?","volume":"343","author":"Epstein","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.545_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-6143.2009.02637.x","article-title":"Factors associated with failure to list HIV-positive kidney transplant candidates","volume":"9","author":"Sawinski","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2010.545_bb0175","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00007890-199301000-00019","article-title":"The effect of cyclosporine on the progression of human immunodeficiency virus type 1 infection transmitted by transplantation--data on four cases and review of the literature","volume":"55","author":"Schwarz","year":"1993","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.545_bb0180","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1157\/13076177","article-title":"Renal transplantation in patients with HIV infection","volume":"23","author":"Trull\u00e1s","year":"2005","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1038\/ki.2010.545_bb0185","first-page":"2161","article-title":"Observations relating to the incidence of the acquired immune deficiency syndrome and other possibly associated conditions in a large population of renal transplant recipients","volume":"19","author":"Feduska","year":"1987","journal-title":"Transplant Proc"},{"key":"10.1038\/ki.2010.545_bb0190","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/0003-4819-106-2-244","article-title":"Transmission of human immunodeficiency virus by transplantation of a renal allograft, with development of the acquired immunodeficiency syndrome","volume":"106","author":"Kumar","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.2010.545_bb0195","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/oxfordjournals.ndt.a091728","article-title":"Acquired immunodeficiency syndrome transmitted by transplanted kidney: clinical course during maintenance haemodialysis","volume":"3","author":"Imbasciati","year":"1988","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 2","key":"10.1038\/ki.2010.545_bb0200","first-page":"75","article-title":"Acquired immunodeficiency syndrome in a transplant patient","volume":"17","author":"Milgrom","year":"1985","journal-title":"Transplant Proc"},{"key":"10.1038\/ki.2010.545_bb0205","first-page":"1400","article-title":"Unusual immune deficiency syndrome associated with LAV\/HTLV-III in a kidney transplant recipient","volume":"18","author":"Lang","year":"1986","journal-title":"Transplant Proc"},{"key":"10.1038\/ki.2010.545_bb0210","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/00007890-198904000-00031","article-title":"HIV infection in cadaveric renal allograft recipients in the North Italy Transplant Program","volume":"47","author":"Poli","year":"1989","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.545_bb0215","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/clinids\/13.4.537","article-title":"HIV infection in patients with solid-organ transplants: report of five cases and review","volume":"13","author":"Erice","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.1038\/ki.2010.545_bb0220","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0140-6736(85)90041-8","article-title":"Transmission of AIDS virus at renal transplantation","volume":"2","author":"Prompt","year":"1985","journal-title":"Lancet"},{"key":"10.1038\/ki.2010.545_bb0225","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0140-6736(85)92654-6","article-title":"HTLV-III infection in kidney transplant recipients","volume":"2","author":"L\u2019age-Stehr","year":"1985","journal-title":"Lancet"},{"key":"10.1038\/ki.2010.545_bb0230","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00007890-198707000-00006","article-title":"Human immunodeficiency virus transmission by organ donation. Outcome in cornea and kidney recipients","volume":"44","author":"Schwarz","year":"1987","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.545_bb0235","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(86)90082-6","article-title":"HIV infection in renal allograft recipients","volume":"2","author":"Margreiter","year":"1986","journal-title":"Lancet"},{"key":"10.1038\/ki.2010.545_bb0240","first-page":"1046","article-title":"HIV infection caused by kidney transplant: case report and review of 18 published cases","volume":"119","author":"Briner","year":"1989","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1038\/ki.2010.545_bb0245","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1159\/000169147","article-title":"Long-term survival in an HIV-infected transplant recipient","volume":"17","author":"Ahuja","year":"1997","journal-title":"Am J Nephrol"},{"key":"10.1038\/ki.2010.545_bb0250","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJM199203123261102","article-title":"Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor","volume":"326","author":"Simonds","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.545_bb0255","doi-asserted-by":"crossref","first-page":"46","DOI":"10.7326\/0003-4819-108-1-46","article-title":"Transmission of human immunodeficiency virus (HIV) by transplantation: clinical aspects and time course analysis of viral antigenemia and antibody production","volume":"108","author":"Bowen","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.2010.545_bb0260","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/00007890-198904000-00030","article-title":"Acute human immunodeficiency virus infection. Antigen detection and seroconversion in immunosuppressed patients","volume":"47","author":"Ward","year":"1989","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.545_bb0265","first-page":"2172","article-title":"Investigation of human T-lymphotropic virus III serology in a renal transplant population","volume":"19","author":"Kerman","year":"1987","journal-title":"Transplant Proc"},{"key":"10.1038\/ki.2010.545_bb0270","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0272-6386(88)80051-9","article-title":"Determination of acquired immunodeficiency syndrome (AIDS) after renal transplantation","volume":"11","author":"Carbone","year":"1988","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2010.545_bb0275","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00007890-199002000-00025","article-title":"Transplantation in HIV+ patients","volume":"49","author":"Tzakis","year":"1990","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.545_bb0280","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1034\/j.1399-3062.2002.01009.x","article-title":"Impact of HIV seropositivity on graft and patient survival after cadaveric renal transplantation in the United States in the pre highly active antiretroviral therapy (HAART) era: an historical cohort analysis of the United States Renal Data System","volume":"4","author":"Swanson","year":"2002","journal-title":"Transpl Infect Dis"},{"key":"10.1038\/ki.2010.545_bb0285","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/01.ASN.0000127987.19470.3A","article-title":"Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression","volume":"15","author":"Abbott","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.545_bb0290","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1097\/01.tp.0000226074.97314.e0","article-title":"HIV-positive renal recipients can achieve survival rates similar to those of HIV-negative patients","volume":"81","author":"Qiu","year":"2006","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.545_bb0295","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1034\/j.1600-6143.2001.010104.x","article-title":"Transplantation in the HIV+ patient","volume":"1","author":"Kuo","year":"2001","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2010.545_bb0300","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1016\/S0041-1345(01)02569-6","article-title":"Solid organ transplantation in HIV-positive patients","volume":"33","author":"Stock","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1038\/ki.2010.545_bb0305","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/01.TP.0000046943.35335.18","article-title":"Review of solid-organ transplantation in HIV-infected patients","volume":"75","author":"Roland","year":"2003","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.545_bb0310","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1034\/j.1600-6143.2003.00119.x","article-title":"Kidney-pancreas transplantation in a long-term non-progressor HIV-infected recipient","volume":"3","author":"Toso","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2010.545_bb0315","first-page":"174","article-title":"Kidney transplantation in HIV positive end stage renal disease patients-a prospective study","volume":"2","author":"Kumar","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2010.545_bb0320","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/01.TP.0000075973.73064.A6","article-title":"Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study","volume":"76","author":"Stock","year":"2003","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.545_bb0325","first-page":"113","article-title":"Renal transplantation in HIV-infected patients in Spain","volume":"26","author":"Mazuecos","year":"2006","journal-title":"Nefrologia"},{"key":"10.1038\/ki.2010.545_bb0330","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/j.1523-1755.2005.00245.x","article-title":"Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients","volume":"67","author":"Kumar","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.545_bb0335","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-6143.2007.02061.x","article-title":"HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes","volume":"8","author":"Roland","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2010.545_bb0340","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/TP.0b013e318177884e","article-title":"Preliminary experience with renal transplantation in HIV+ recipients: low acute rejection and infection rates","volume":"86","author":"Gruber","year":"2008","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.545_bb0345","first-page":"194","article-title":"HIV and solid organ transplantation: the Swiss experience","volume":"136","author":"M\u00fcller","year":"2006","journal-title":"Swiss Med Wkly"},{"key":"10.1038\/ki.2010.545_bb0350","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1097\/QAD.0b013e32830f4c8d","article-title":"Combined liver-kidney transplantation in an HIV-HCV-coinfected patient with haemophilia","volume":"22","author":"Ballarin","year":"2008","journal-title":"AIDS"},{"key":"10.1038\/ki.2010.545_bb0355","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1089\/aid.2007.0015","article-title":"Effect of thymoglobulin induction on HIV-infected renal transplant recipients: differences between HIV-positive and HIV-negative patients","volume":"23","author":"Trullas","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1038\/ki.2010.545_bb0360","series-title":"Infecci\u00f3n VIH y trasplante renal: un estudio de casos y controles en Espa\u00f1a","author":"Mazuecos","year":"2010"},{"key":"10.1038\/ki.2010.545_bb0365","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1016\/j.transproceed.2009.08.039","article-title":"Kidney transplantation in HIV-positive patients: report of our first 7 cases","volume":"41","author":"Billault","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1038\/ki.2010.545_bb0370","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1111\/j.1600-6143.2010.03258.x","article-title":"Renal transplantation in HIV-infected patients: the Paris experience","volume":"10","author":"Touzot","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2010.545_bb0375","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMoa1001197","article-title":"Outcomes of kidney transplantation in HIV-infected recipients","volume":"363","author":"Stock","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.545_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-6143.2009.02684.x","article-title":"Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs","volume":"9","author":"Tricot","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2010.545_bb0385","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.4049\/jimmunol.180.7.4714","article-title":"Combined CXCR3\/CCR5 blockade attenuates acute and chronic rejection","volume":"180","author":"Schnickel","year":"2008","journal-title":"J Immunol"},{"key":"10.1038\/ki.2010.545_bb0390","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0140-6736(00)04898-4","article-title":"CC chemokine receptor 5 and renal-transplant survival","volume":"357","author":"Fischereder","year":"2001","journal-title":"Lancet"},{"key":"10.1038\/ki.2010.545_bb0395","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/430257","article-title":"Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America","volume":"40","author":"Gupta","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1038\/ki.2010.545_rf0400","first-page":"362.e1","article-title":"AIDS Study Group\/Spanish AIDS Plan consensus document on antiretroviral therapy in adults with human immunodeficiency virus infection (updated January 2010)","volume":"28","author":"Panel de expertos de Gesida; Plan Nacional sobre el Sida","year":"2010","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1038\/ki.2010.545_bb0405","unstructured":"Antiretroviral agents product information. European Medicines Agency (EMEA). EPARs for authorised medicinal products for human use Available at: http:\/\/www.emea.europa.eu\/htms\/human\/epar\/a.htm (accessed 10 March 2010)"},{"key":"10.1038\/ki.2010.545_bb0410","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.2010.1004","article-title":"Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel","volume":"304","author":"Thompson","year":"2010","journal-title":"JAMA"},{"key":"10.1038\/ki.2010.545_bb0415","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/QAD.0b013e32830e011f","article-title":"The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir\/ritonavir in HIV-infected persons requiring hemodialysis","volume":"22","author":"Gupta","year":"2008","journal-title":"AIDS"},{"key":"10.1038\/ki.2010.545_bb0420","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/00002030-199811000-00025","article-title":"Indinavir pharmacokinetics in haemodialysis-dependent end-stage renal failure","volume":"12","author":"Guardiola","year":"1998","journal-title":"AIDS"},{"key":"10.1038\/ki.2010.545_bb0425","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00126334-199908150-00005","article-title":"Antiviral therapy for HIV patients with renal insufficiency","volume":"21","author":"Jayasekara","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1038\/ki.2010.545_bb0430","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/ndt\/16.3.642","article-title":"Lack of removal of nelfinavir during a haemodialysis session in an HIV-1 infected patient with hepatic and renal insufficiency","volume":"16","author":"Paci-Bonaventure","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2010.545_bb0435","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2165\/00003088-200645110-00005","article-title":"Pharmacokinetics and dosing recommendations of tenofovir disoproxil fumarate in hepatic or renal impairment","volume":"45","author":"Kearney","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"10.1038\/ki.2010.545_bb0440","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1128\/AAC.01115-06","article-title":"Steady-state disposition of the nonpeptidic protease inhibitor tipranavir when coadministered with ritonavir","volume":"51","author":"Chen","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1038\/ki.2010.545_bb0445","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/00002030-200005260-00021","article-title":"Efavirenz dosing in patients receiving continuous ambulatory peritoneal dialysis","volume":"14","author":"Gill","year":"2000","journal-title":"AIDS"},{"key":"10.1038\/ki.2010.545_bb0450","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/ndt\/gfg327","article-title":"Pharmacokinetics of tenofovir in haemodialysis","volume":"18","author":"Izzedine","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2010.545_bb0455","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2165\/00003088-200645070-00003","article-title":"Tipranavir: a novel nonpeptidic protease inhibitor of HIV","volume":"45","author":"King","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"10.1038\/ki.2010.545_bb0460","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/QAI.0b013e31816237f0","article-title":"Enfuvirtide does not require dose adjustment in patients with chronic kidney failure: results of a pharmacokinetic study of enfuvirtide in HIV-1-infected patients with impaired kidney function","volume":"47","author":"Tebas","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1038\/ki.2010.545_bb0465","series-title":"Pharmacokinetics of atazanavir in severely renally impaired subjects including those on hemodialysis","author":"Agarwala","year":"2007"},{"key":"10.1038\/ki.2010.545_bb0470","series-title":"Effect of severe renal insufficiency on raltegravir pharmacokinetics","author":"Petry","year":"2007"},{"key":"10.1038\/ki.2010.545_bb0475","series-title":"17th Conference on Retroviruses and Opportunistic Infections","article-title":"Efficacy of ART with NVP_TDF\/FTC vs LPV\/r_TDF\/FTC among antiretroviral-naive women in Africa: OCTANE Trial 2\/ACTG A5208","author":"McIntyre","year":"2010"},{"key":"10.1038\/ki.2010.545_bb0480","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/QAD.0b013e3282f4243b","article-title":"Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV","volume":"22","author":"Pulido","year":"2008","journal-title":"AIDS"},{"key":"10.1038\/ki.2010.545_bb0485","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/QAD.0b013e3283348944","article-title":"The MONET trial: darunavir\/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies\/ml","volume":"24","author":"Arribas","year":"2010","journal-title":"AIDS"},{"key":"10.1038\/ki.2010.545_bb0490","first-page":"182","article-title":"Uniquely South African: time to consider offering HIV-positive donor kidneys to HIV-infected renal failure patients?","volume":"98","author":"Venter","year":"2008","journal-title":"S Afr Med J"},{"key":"10.1038\/ki.2010.545_bb0495","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMc0900837","article-title":"Renal transplantation between HIV-positive donors and recipients","volume":"362","author":"Muller","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.545_bb0500","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0b013e318206fa5d","article-title":"Are HIV-infected donors suitable for renal transplantation?","volume":"91","author":"Cofan","year":"2011","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.545_bb0505","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1432-2277.2007.00483.x","article-title":"Effects of immunosuppressive drugs on HIV infection: implications for solid-organ transplantation","volume":"20","author":"Ciuffreda","year":"2007","journal-title":"Transpl Int"},{"key":"10.1038\/ki.2010.545_bb0510","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/viro.1998.9155","article-title":"Cyclophilin a modulates processing of human immunodeficiency virus type 1 p55Gag: mechanism for antiviral effects of cyclosporin A","volume":"245","author":"Streblow","year":"1998","journal-title":"Virology"},{"key":"10.1038\/ki.2010.545_bb0515","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/77489","article-title":"Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo","volume":"6","author":"Chapuis","year":"2000","journal-title":"Nat Med"},{"key":"10.1038\/ki.2010.545_bb0520","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0166-3542(02)00006-2","article-title":"Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir","volume":"55","author":"Hossain","year":"2002","journal-title":"Antiviral Res"},{"key":"10.1038\/ki.2010.545_bb0525","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2165\/00003088-200443120-00004","article-title":"Effect of mycophenolate mofetil on the pharmacokinetics of antiretroviral drugs and on intracellular nucleoside triphosphate pools","volume":"43","author":"Sankatsing","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1038\/ki.2010.545_bb0530","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1097\/QAD.0b013e3282f02a4f","article-title":"Rapamycin reduces CCR5 mRNA levels in macaques: potential applications in HIV-1 prevention and treatment","volume":"21","author":"Gilliam","year":"2007","journal-title":"AIDS"},{"key":"10.1038\/ki.2010.545_bb0535","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa042831","article-title":"Sirolimus for Kaposi's sarcoma in renal-transplant recipients","volume":"352","author":"Stallone","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.545_bb0540","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1742-6405-7-30","article-title":"Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG Protocol A5051, a rollover trial of ACTG Protocol A328)","volume":"7","author":"Bosch","year":"2010","journal-title":"AIDS Res Ther"},{"key":"10.1038\/ki.2010.545_bb0545","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2006.01238.x","article-title":"Thymoglobulin-associated CD4+ T-cell depletion and infection risk in HIV-infected renal transplant recipients","volume":"6","author":"Carter","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2010.545_bb0550","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1016\/j.transproceed.2007.09.043","article-title":"Single dose of rituximab plus plasmapheresis in an HIV patient with acute humoral kidney transplant rejection: a case report","volume":"39","author":"Moscoso-Solorzano","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1038\/ki.2010.545_bb0555","doi-asserted-by":"crossref","first-page":"914","DOI":"10.7326\/0003-4819-129-11_Part_1-199812010-00022","article-title":"Pharmacokinetic interaction between saquinavir and cyclosporine","volume":"129","author":"Brinkman","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.2010.545_bb0560","series-title":"Effect of coadministered boosted protease inhibitors regimen on tacrolimus blood concentration in 3 kidney transplanted HIV-infected patients","author":"Barrail-Tran","year":"2007"},{"key":"10.1038\/ki.2010.545_bb0565","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1053\/jlts.2002.34880","article-title":"The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients","volume":"8","author":"Jain","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1038\/ki.2010.545_bb0570","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00002030-200202150-00032","article-title":"Probable interaction between efavirenz and cylcosporine","volume":"16","author":"Tseng","year":"2002","journal-title":"AIDS"},{"key":"10.1038\/ki.2010.545_bb0575","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/j.1600-6143.2007.02007.x","article-title":"Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients","volume":"7","author":"Frassetto","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2010.545_bb0580","series-title":"Liver transplantation in HIV-coinfected patients treated with enfuvirtide","author":"Teicher","year":"2006"},{"key":"10.1038\/ki.2010.545_bb0585","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/QAD.0b013e3282f37478","article-title":"Safe use of raltegravir and sirolimus in an HIV-infected patient with renal impairment after orthotopic liver transplantation","volume":"22","author":"Moreno","year":"2008","journal-title":"AIDS"},{"key":"10.1038\/ki.2010.545_bb0590","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.transproceed.2006.02.013","article-title":"Pharmacokinetic interaction between amprenavir\/ritonavir and fosamprenavir on cyclosporine in two patients with human immunodeficiency virus infection undergoing orthotopic liver transplantation","volume":"38","author":"Guaraldi","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1038\/ki.2010.545_bb0595","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00126334-200209010-00006","article-title":"The addition of mycophenolate mofetil to antiretroviral therapy including abacavir is associated with depletion of intracellular deoxyguanosine triphosphate and a decrease in plasma HIV-1 RNA","volume":"31","author":"Margolis","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1038\/ki.2010.545_bb0600","series-title":"Pharmacokinetic evaluation of antiretroviral and immunosuppressive therapy in acute HIV infection following solid-organ transplantation","author":"Regazzi","year":"2008"},{"key":"10.1038\/ki.2010.545_bb0605","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/jlts.2003.50054","article-title":"Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease","volume":"9","author":"Neff","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1038\/ki.2010.545_bb0610","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1345\/aph.1D076","article-title":"Tacrolimus and lopinavir\/ritonavir interaction in liver transplantation","volume":"37","author":"Schonder","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1038\/ki.2010.545_bb0615","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00007890-199907270-00027","article-title":"Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels","volume":"68","author":"Sheikh","year":"1999","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.545_bb0620","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/lt.20165","article-title":"Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir\/ritonavir in liver-transplanted HIV-infected patients","volume":"10","author":"Vogel","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1038\/ki.2010.545_or0030","unstructured":"Tuset M, Miro J.M., Codina C et al. eds. Antiretroviral agents drug-drug interactions website (Spanish) Available at: http:\/\/www.interaccioneshiv.com\/ (accessed 10 March 2010)"},{"key":"10.1038\/ki.2010.545_bb0630","unstructured":"Back D, Gibbons S. The University of Liverpool HIV drug interactions website: http:\/\/www.hiv-druginteractions.org (accessed 10 March 2010)"},{"key":"10.1038\/ki.2010.545_bb0635","unstructured":"Certican (everolimus) product information. Novartis Pharma Stein AG: Switzerland Available at: http:\/\/www.health.gov.il\/units\/pharmacy\/trufot\/alonim\/2256.pdf (accessed 10 March 2010)"},{"key":"10.1038\/ki.2010.545_bb0640","unstructured":"Prograf (tacrolimus) prescribing information. Astellas Pharma US Available at: http:\/\/www.astellas.us\/docs\/prograf.pdf [accessed 4 January 2011]"},{"key":"10.1038\/ki.2010.545_bb0645","unstructured":"Rapamune (sirolimus) product information. European Medicines Agency (EMEA). EPARs for authorised medicinal products for human use. Available at: http:\/\/www.emea.europa.eu\/htms\/human\/epar\/a.htm (accessed 10 March 2010)"},{"key":"10.1038\/ki.2010.545_bb0650","series-title":"Sandimmune (cyclosporine) product information","year":"2007"},{"key":"10.1038\/ki.2010.545_bb0655","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1046\/j.1600-6143.2004.00606.x","article-title":"The impact of transplantation with deceased donor hepatitis c-positive kidneys on survival in wait-listed long-term dialysis patients","volume":"4","author":"Abbott","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2010.545_bb0660","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.ajkd.2003.09.018","article-title":"The impact of hepatitis C virus viremia on renal graft and patient survival: a 9-year prospective study","volume":"43","author":"Mahmoud","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2010.545_bb0665","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/ndt\/gfh747","article-title":"Pegylated interferon for the treatment of hepatitis C virus in haemodialysis patients","volume":"20","author":"Teta","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2010.545_bb0670","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/01.TP.0000128911.87538.AA","article-title":"Histopathologic efficacy of ribavirin monotherapy in kidney allograft recipients with chronic hepatitis C","volume":"78","author":"Fontaine","year":"2004","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.545_bb0675","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1097\/01.TP.0000158279.29506.E0","article-title":"Lack of evidence for ribavirin monotherapy efficacy on liver fibrosis in hepatitis C virus positive renal transplant patients","volume":"79","author":"Kamar","year":"2005","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.545_bb0680","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/TP.0b013e318160254f","article-title":"Risk factors for cardiovascular events after successful renal transplantation","volume":"85","author":"Vanrenterghem","year":"2008","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.545_bb0685","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2165\/00003495-200868070-00006","article-title":"Renal disease in patients with HIV infection: epidemiology, pathogenesis and management","volume":"68","author":"Fine","year":"2008","journal-title":"Drugs"},{"key":"10.1038\/ki.2010.545_bb0690","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1001\/archinte.163.15.1773","article-title":"Key clinical, ethical, and policy issues in the evaluation of the safety and effectiveness of solid organ transplantation in HIV-infected patients","volume":"163","author":"Roland","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1038\/ki.2010.545_bb0695","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1016\/j.transproceed.2010.09.003","article-title":"Pancreas-kidney transplantation in an HIV-infected patient treated with raltegravir: case report and literature review","volume":"42","author":"Miro","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1038\/ki.2010.545_bb0700","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.transproceed.2010.01.007","article-title":"Simultaneous pancreas-kidney transplantation in a human immunodeficiency virus-positive recipient: a case report","volume":"42","author":"Genzini","year":"2010","journal-title":"Transplant Proc"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815548965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815548965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T20:17:48Z","timestamp":1559938668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815548965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":139,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0085253815548965"],"URL":"https:\/\/doi.org\/10.1038\/ki.2010.545","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}